BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 917 filers reported holding BAXTER INTL INC in Q4 2013. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $25,712,000 | +5.8% | 293,955 | -1.0% | 0.42% | -2.6% |
Q2 2019 | $24,308,000 | +13.0% | 296,805 | +12.2% | 0.43% | +8.6% |
Q1 2019 | $21,515,000 | +2.4% | 264,605 | -17.1% | 0.40% | -6.8% |
Q4 2018 | $21,003,000 | -18.4% | 319,105 | -4.5% | 0.42% | -4.1% |
Q3 2018 | $25,748,000 | -10.7% | 334,005 | -14.4% | 0.44% | -14.2% |
Q2 2018 | $28,828,000 | +0.1% | 390,405 | -11.9% | 0.52% | +0.4% |
Q1 2018 | $28,813,000 | -2.4% | 443,005 | -3.0% | 0.51% | +1.8% |
Q4 2017 | $29,521,000 | +27.4% | 456,705 | +23.7% | 0.50% | +21.7% |
Q3 2017 | $23,168,000 | +32.0% | 369,205 | +27.4% | 0.41% | +27.8% |
Q2 2017 | $17,551,000 | -41.8% | 289,905 | -50.1% | 0.32% | -42.2% |
Q1 2017 | $30,146,000 | +39.7% | 581,305 | +19.4% | 0.56% | +34.2% |
Q4 2016 | $21,580,000 | +1.8% | 486,705 | +9.2% | 0.42% | 0.0% |
Q3 2016 | $21,206,000 | +27.3% | 445,505 | +20.9% | 0.42% | +21.2% |
Q2 2016 | $16,659,000 | +66.6% | 368,400 | +51.4% | 0.34% | +62.7% |
Q1 2016 | $9,999,000 | -42.8% | 243,405 | -46.9% | 0.21% | -44.2% |
Q4 2015 | $17,485,000 | +12.7% | 458,323 | -3.0% | 0.38% | +11.8% |
Q3 2015 | $15,519,000 | -55.6% | 472,418 | -5.5% | 0.34% | -52.0% |
Q2 2015 | $34,971,000 | -25.3% | 500,084 | -26.9% | 0.71% | -22.9% |
Q1 2015 | $46,841,000 | +52.8% | 683,813 | +63.5% | 0.92% | +39.7% |
Q4 2014 | $30,651,000 | +2.2% | 418,212 | +0.0% | 0.66% | -0.6% |
Q3 2014 | $30,001,000 | -37.7% | 418,014 | -37.2% | 0.66% | -33.0% |
Q2 2014 | $48,138,000 | -9.6% | 665,807 | -8.0% | 0.99% | -2.7% |
Q1 2014 | $53,247,000 | +2.1% | 723,660 | -3.5% | 1.01% | +0.3% |
Q4 2013 | $52,158,000 | +8450.5% | 749,936 | +7981.2% | 1.01% | +7676.9% |
Q3 2013 | $610,000 | -5.9% | 9,280 | -0.8% | 0.01% | -7.1% |
Q2 2013 | $648,000 | – | 9,355 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |